Association of programmed cell death ligand 1 and circulating lymphocytes with risk of venous thromboembolism in patients with glioma

INTRODUCTION: The role of the adaptive immune system in the pathophysiology of cancer-associated venous thromboembolism (VTE) has not been investigated in detail. Programmed cell death ligand 1 (PD-L1) is an immune checkpoint molecule responsible for immune evasion in several cancer entities, as exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Mir Seyed Nazari, Pegah, Berghoff, Anna S, Preusser, Matthias, Moik, Florian, Posch, Florian, Ricken, Gerda, Riedl, Julia, Hell, Lena, Marosi, Christine, Hainfellner, Johannes A, Pabinger, Ingrid, Ay, Cihan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239522/
https://www.ncbi.nlm.nih.gov/pubmed/32424065
http://dx.doi.org/10.1136/esmoopen-2019-000647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239522/
https://www.ncbi.nlm.nih.gov/pubmed/32424065
http://dx.doi.org/10.1136/esmoopen-2019-000647

Ejemplares similares